Simplex Secures Investment from Camelot Venture Group

David Katzman to Join Board of Directors

Brentwood, Tennessee (June 10 2009) - Simplex Healthcare announced today a growth equity investment from Camelot Venture Group of Farmington Hills, Michigan. As part of this investment, Camelot Managing Partner David Katzman will join the Simplex Board of Directors.

"Simplex is very fortunate to have Camelot as part of our investment group and David as part of the board," said CEO Doug Hudson, Chairman and CEO of Simplex. "I've known David for many years and his direct to consumer experience and marketing expertise will be invaluable to Simplex."

Simplex, a leading provider of diabetic testing supplies, has grown dramatically since it was founded in 2007. The Center for Disease Control estimates that nearly 21 million Americans are diabetic and an additional 41 million are pre-diabetic (elevated blood sugar levels). Almost 1.3 million new diabetics are diagnosed each year with the expectation that this will continue to grow due to an aging population and increased obesity in the US.

"I'm excited to be a part of Simplex" said David Katzman. "Doug, his management team and the board have done an impressive job of building the company to this point. I look forward to helping them expand their vision and growth."

About Camelot Venture Group
Camelot Venture Group is a private investment group that invests primarily in direct to consumer companies including online, retail, technology and financial services and sports management. Camelot provides their investment partners operational expertise and capital for accelerated growth. For more information, go to www.CamelotVentureGroup.com

About Simplex Healthcare, Inc
Simplex and its subsidiary, Diabetes Care Club (www.diabetescareclub.com), have grown rapidly and now serve over 135,000 active patients with Diabetes. The company employs over 240 professionals and is based in Nashville, Tennessee with operations in Brentwood and Franklin.